CTSO

CTSO

Cytosorbents Corporation Common Stock

$1.090+-0.000 (-0.000%)

リアルタイム価格

価格チャート

Loading Chart...

主要指標

市場指標
企業ファンダメンタルズ
取引統計

市場指標

始値

$1.090

高値

$1.090

安値

$1.090

出来高

0.01M

企業ファンダメンタルズ

取引統計

関連ニュース

PR Newswire

CytoSorbents Therapy Significantly Reduces Bleeding in Urgent CABG Patients on Ticagrelor in New Data Presented at EuroPCR 2025

CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...

もっと見る
CytoSorbents Therapy Significantly Reduces Bleeding in Urgent CABG Patients on Ticagrelor in New Data Presented at EuroPCR 2025
Analyst Upgrades

D. Boral Capital Maintains Buy on CytoSorbents, Maintains $10 Price Target

D. Boral Capital analyst Jason Kolbert maintains CytoSorbents with a Buy and maintains $10 price target.

もっと見る
D. Boral Capital Maintains Buy on CytoSorbents, Maintains $10 Price Target
Analyst Upgrades

HC Wainwright & Co. Reiterates Neutral on CytoSorbents, Maintains $1 Price Target

HC Wainwright & Co. analyst Sean Lee reiterates CytoSorbents with a Neutral and maintains $1 price target.

もっと見る
HC Wainwright & Co. Reiterates Neutral on CytoSorbents, Maintains $1 Price Target
PR Newswire

CytoSorbents Reports First Quarter 2025 Financial Results and Provides Business Update

CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...

もっと見る
CytoSorbents Reports First Quarter 2025 Financial Results and Provides Business Update
Analyst Upgrades

D. Boral Capital Maintains Buy on CytoSorbents, Maintains $10 Price Target

D. Boral Capital analyst Jason Kolbert maintains CytoSorbents with a Buy and maintains $10 price target.

もっと見る
D. Boral Capital Maintains Buy on CytoSorbents, Maintains $10 Price Target